Cargando…
Remdesivir treatment and clinical outcome in non-severe hospitalized COVID-19 patients: a propensity score matching multicenter Italian hospital experience
INTRODUCTION: Remdesivir exerts positive effects on clinical improvement, even though it seems not to affect mortality among COVID-19 patients; moreover, it was associated with the occurence of marked bradycardia. METHODS: We retrospectively evaluated 989 consecutive patients with non-severe COVID-1...
Autores principales: | Attena, Emilio, Caturano, Alfredo, Annunziata, Anna, Maraolo, Alberto Enrico, De Rosa, Annunziata, Fusco, Francesco Maria, Halasz, Geza, Dall’Ospedale, Valeria, Conte, Maddalena, Parisi, Valentina, Galiero, Raffaele, Sasso, Ferdinando Carlo, Fiorentino, Giuseppe, Russo, Vincenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201037/ https://www.ncbi.nlm.nih.gov/pubmed/37212843 http://dx.doi.org/10.1007/s00228-023-03499-z |
Ejemplares similares
-
The prognostic role of interatrial block among COVID‐19 patients hospitalized in medicine wards
por: Russo, Vincenzo, et al.
Publicado: (2022) -
HCC and Molecular Targeting Therapies: Back to the Future
por: Rinaldi, Luca, et al.
Publicado: (2021) -
Remdesivir in Severe COVID-19 and Non-Invasive Ventilation: A Real-Life Experience
por: Simioli, Francesca, et al.
Publicado: (2021) -
Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies
por: Vetrano, Erica, et al.
Publicado: (2023) -
Precision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations
por: Galiero, Raffaele, et al.
Publicado: (2023)